LivaNova (LIVN) Shares Outstanding (Diluted) (2014 - 2026)
LivaNova (LIVN) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 176.62 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 108.72 Bn | 99.50 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.85 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 393.60 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 457.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | 873.00 Mn |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 968.53 Mn |
| 10 | LivaNova | 4.39 Bn | 3.85 Bn | 243.75 Mn | 55.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.94 Mn |
| Dec 31, 2025 | 54.55 Mn |
| Sep 30, 2025 | 55.15 Mn |
| Jun 30, 2025 | 54.71 Mn |
| Mar 31, 2025 | 54.42 Mn |
| Dec 31, 2024 | 54.57 Mn |
| Sep 30, 2024 | 54.59 Mn |
| Jun 30, 2024 | 54.59 Mn |
| Mar 31, 2024 | 54.01 Mn |
| Dec 31, 2023 | 54.21 Mn |
| Sep 30, 2023 | 53.99 Mn |
| Jun 30, 2023 | 53.98 Mn |
| Mar 31, 2023 | 53.90 Mn |
| Dec 31, 2022 | 53.47 Mn |
| Sep 30, 2022 | 53.53 Mn |
| Jun 30, 2022 | 54.08 Mn |
| Mar 31, 2022 | 54.18 Mn |
| Dec 31, 2021 | 50.63 Mn |
| Sep 30, 2021 | 51.58 Mn |
| Jun 30, 2021 | 48.93 Mn |